Odenthal, Germany

Hans-Rolf Taterra

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Rolf Taterra. Retrieved from https://idiyas.com/inventor/hans-rolf-taterra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hans-Rolf Taterra

Introduction

Hans-Rolf Taterra is a notable inventor based in Odenthal, Germany. He has made significant contributions to the field of vitamin stabilization through his innovative inventions. With a total of two patents to his name, Taterra's work has garnered attention in the scientific community.

Latest Patents

Taterra's latest patents focus on preparations that comprise vitamin B and butanol. His inventions explore the use of butanol for stabilizing vitamins, which is crucial for enhancing the efficacy and shelf-life of vitamin formulations. These patents reflect his commitment to advancing nutritional science and improving health outcomes.

Career Highlights

Hans-Rolf Taterra is associated with Bayer Intellectual Property GmbH, where he continues to develop and refine his innovative ideas. His work at Bayer has allowed him to collaborate with leading experts in the field, further enhancing the impact of his inventions.

Collaborations

Taterra has worked alongside his coworker, Iris Heep, contributing to the development of groundbreaking solutions in the realm of vitamin stabilization. Their collaboration exemplifies the importance of teamwork in driving innovation.

Conclusion

Hans-Rolf Taterra's contributions to the field of vitamin stabilization through his patents demonstrate his dedication to innovation and health. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…